Meert, Anne-Pascale http://orcid.org/0000-0003-1158-5502
Wittnebel, Sebastian
Holbrechts, Stéphane
Toffart, Anne-Claire
Lafitte, Jean-Jacques
Piagnerelli, Michael
Lemaitre, France
Peyrony, Olivier
Calvel, Laurent
Lemaitre, Jean
Canet, Emmanuel
Demoule, Alexandre
Darmon, Michael
Sculier, Jean-Paul
Voigt, Louis
Lemiale, Virginie
Pène, Frédéric
Schnell, David
Lengline, Etienne
Berghmans, Thierry
Fiévet, Laurence
Jungels, Christiane
Wang, Xiaoxiao
Bold, Ionela
Pistone, Aureliano
Salaroli, Adriano
Grigoriu, Bogdan
Benoit, Dominique
Meert, Anne-Pascale
Wittnebel, Sebastian
Holbrechts, Stéphane
Toffart, Anne-Claire
Lafitte, Jean-Jacques
Piagnerelli, Michael
Lemaitre, France
Peyrony, Olivier
Calvel, Laurent
Lemaitre, Jean
Canet, Emmanuel
Demoule, Alexandre
Darmon, Michael
Sculier, Jean-Paul
Voigt, Louis
Lemiale, Virginie
Pène, Frédéric
Schnell, David
Lengline, Etienne
Berghmans, Thierry
Fiévet, Laurence
Jungels, Christiane
Wang, Xiaoxiao
Bold, Ionela
Pistone, Aureliano
Salaroli, Adriano
Grigoriu, Bogdan
Benoit, Dominique
Quoix, Elisabeth
Meuleman, Nathalie
Mokart, Djamel
Durieux, Valérie
Peltgen, Dominique
Leclercq, Nathalie
Vanmeerhaeghe, Alain
,
Funding for this research was provided by:
Les Amis de l'Institut Jules Bordet
Article History
Received: 25 January 2021
Accepted: 10 August 2021
First Online: 20 September 2021
Declarations
:
: APM declares having received grant from BMS outside the submitted work. DB reports grants from Gilead, Astellas, Fisher-Paykel, Baxter, Alexion and Fresenius Kabi outside the submitted work. ACT reports grants, personal fees and non-financial support from Roche, personal fees and non-financial support from Astra Zeneca, personal fees and non-financial support from BMS, personal fees and non-financial support from MSD, grants, personal fees and non-financial support from Pfizer, personal fees and non-financial support from Boehringer Ingelheim, personal fees and non-financial support from Vifor Pharma, personal fees and non-financial support from Novartis, personal fees from Amgen, outside the submitted work. EC received fees from Gilead and Sanofi Aventis for lectures and transport accommodation. AD reports personal fees from Medtronic, grants, personal fees and non-financial support from Philips, personal fees from Baxter, personal fees from Hamilton, personal fees and non-financial support from Fisher and Paykel, grants from French Ministry of Health, personal fees from Getinge, grants and personal fees from Respinor, grants and non-financial support from Lungpacer, outside the submitted work. MD declares having recieved speaker fees from Astelas, Gilead and MSD and declare having received a research grant from MSD. VL is treasorier of research group who received fee from Pfizer, Fisher-Paykel, Gilead, Astellas, Alexion. FP received institutional grant from ALEXION PHARMA. JP Sculier none.
Free to read: This content has been made available to all.